151 related articles for article (PubMed ID: 11972519)
1. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease.
Carbone A; Gloghini A; Aldinucci D; Gattei V; Dalla-Favera R; Gaidano G
Br J Haematol; 2002 May; 117(2):366-72. PubMed ID: 11972519
[TBL] [Abstract][Full Text] [Related]
2. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.
Carbone A; Gloghini A; Gaidano G; Franceschi S; Capello D; Drexler HG; Falini B; Dalla-Favera R
Blood; 1998 Oct; 92(7):2220-8. PubMed ID: 9746758
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
Kraus MD; Haley J
Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
[TBL] [Abstract][Full Text] [Related]
4. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease.
Falini B; Bigerna B; Pasqualucci L; Fizzotti M; Martelli MF; Pileri S; Pinto A; Carbone A; Venturi S; Pacini R; Cattoretti G; Pescarmona E; Lo Coco F; Pelicci PG; Anagnastopoulos I; Dalla-Favera R; Flenghi L
Blood; 1996 Jan; 87(2):465-71. PubMed ID: 8555467
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.
Carbone A; Gloghini A; Larocca LM; Antinori A; Falini B; Tirelli U; Dalla-Favera R; Gaidano G
Blood; 1999 Apr; 93(7):2319-26. PubMed ID: 10090942
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells.
Falini B; Fizzotti M; Pucciarini A; Bigerna B; Marafioti T; Gambacorta M; Pacini R; Alunni C; Natali-Tanci L; Ugolini B; Sebastiani C; Cattoretti G; Pileri S; Dalla-Favera R; Stein H
Blood; 2000 Mar; 95(6):2084-92. PubMed ID: 10706878
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.
Torlakovic E; Tierens A; Dang HD; Delabie J
Am J Pathol; 2001 Nov; 159(5):1807-14. PubMed ID: 11696441
[TBL] [Abstract][Full Text] [Related]
8. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
9. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
[TBL] [Abstract][Full Text] [Related]
10. Expression of the proliferating cell nuclear antigen in the different types of Hodgkin's disease.
Hell K; Lorenzen J; Hansmann ML; Fellbaum C; Busch R; Fischer R
Am J Clin Pathol; 1993 May; 99(5):598-603. PubMed ID: 7684186
[TBL] [Abstract][Full Text] [Related]
11. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
12. Phenotype of Hodgkin and Sternberg-Reed cells and expression of CD57 (LEU7) antigen.
Papadimitriou CS; Bai MK; Kotsianti AJ; Costopoulos JS; Hytiroglou P
Leuk Lymphoma; 1995 Dec; 20(1-2):125-30. PubMed ID: 8750633
[TBL] [Abstract][Full Text] [Related]
13. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
[TBL] [Abstract][Full Text] [Related]
14. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
Hansmann ML; Küppers R
Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
16. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
[TBL] [Abstract][Full Text] [Related]
17. Expression of cell adhesion molecules associated with germinal center in Hodgkin's disease: an immunohistochemical study. The germinal center related complex and histologic subtypes.
Ree HJ; Khan AA; Qureshi MN; Teplitz C
Cancer; 1994 Feb; 73(4):1257-63. PubMed ID: 7906194
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
Pinkus GS; Said JW
Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
Hsu SM; Xie SS; Hsu PL; Waldron JA
Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
[TBL] [Abstract][Full Text] [Related]
20. [Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis].
Carbonnelle A; Delarue R; Canioni D; Brousse N
Ann Pathol; 2004 Apr; 24(2):136-48; quiz 135. PubMed ID: 15220833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]